Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Moretta

Showing results (41-50 of 205) with videos related to

Pageof 21
Sort By:
Blood|October 29, 2005
The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophilsAriel Munitz, Ido Bachelet, Ron Eliashar, et al.
Immunology Letters|August 20, 2005
Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysisLorenzo Moretta, Cristina Bottino, Daniela Pende, et al.
The Journal of Investigative Dermatology|December 31, 2010
Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patientsArmand Bensussan, Natacha Remtoula, Simona Sivori, et al.
Immunology Letters|July 26, 2003
Cellular and molecular basis of natural killer and natural killer-like activityLorenzo Moretta, Maria Cristina Mingari, Cristina Bottino, et al.
Seminars in Immunology|March 4, 2014
Human NK cell response to pathogensMariella Della Chiesa, Emanuela Marcenaro, Simona Sivori, et al.
European Journal of Immunology|June 5, 2003
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptorsMariella Della Chiesa, Massimo Vitale, Simona Carlomagno, et al.
Trends in Immunology|November 9, 2004
Different checkpoints in human NK-cell activationLorenzo Moretta, Cristina Bottino, Daniela Pende, et al.
Trends in Immunology|May 26, 2018
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute LeukemiaFranco Locatelli, Daniela Pende, Michela Falco, et al.
Clinical Immunology (Orlando, Fla.)|June 2, 2009
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the differenceFranco Locatelli, Daniela Pende, Rita Maccario, et al.
Frontiers in Immunology|January 1, 2014
Impact of HCMV Infection on NK Cell Development and Function after HSCTMariella Della Chiesa, Michela Falco, Letizia Muccio, et al.
Pageof 21

Showing results (41-50 of 205) with videos related to

Sort By:
Pageof 21
Blood|October 29, 2005
The inhibitory receptor IRp60 (CD300a) suppresses the effects of IL-5, GM-CSF, and eotaxin on human peripheral blood eosinophilsAriel Munitz, Ido Bachelet, Ron Eliashar, et al.
Immunology Letters|August 20, 2005
Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysisLorenzo Moretta, Cristina Bottino, Daniela Pende, et al.
The Journal of Investigative Dermatology|December 31, 2010
Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patientsArmand Bensussan, Natacha Remtoula, Simona Sivori, et al.
Immunology Letters|July 26, 2003
Cellular and molecular basis of natural killer and natural killer-like activityLorenzo Moretta, Maria Cristina Mingari, Cristina Bottino, et al.
Seminars in Immunology|March 4, 2014
Human NK cell response to pathogensMariella Della Chiesa, Emanuela Marcenaro, Simona Sivori, et al.
European Journal of Immunology|June 5, 2003
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptorsMariella Della Chiesa, Massimo Vitale, Simona Carlomagno, et al.
Trends in Immunology|November 9, 2004
Different checkpoints in human NK-cell activationLorenzo Moretta, Cristina Bottino, Daniela Pende, et al.
Trends in Immunology|May 26, 2018
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute LeukemiaFranco Locatelli, Daniela Pende, Michela Falco, et al.
Clinical Immunology (Orlando, Fla.)|June 2, 2009
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the differenceFranco Locatelli, Daniela Pende, Rita Maccario, et al.
Frontiers in Immunology|January 1, 2014
Impact of HCMV Infection on NK Cell Development and Function after HSCTMariella Della Chiesa, Michela Falco, Letizia Muccio, et al.
Pageof 21